Informations générales (source: ClinicalTrials.gov)
Rehabilitation Improved by Early Detection of Fisyulas Post (Pharyngo) -Total Laryngectomy by Cytokine Measurement on Drainage Fluid on the Second Post-Operative Day
Interventional
N/A
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
février 2025
mai 2028
02 octobre 2025
Post-pharyngo-laryngectomy fistula is a frequent surgical complication, resulting in
delayed patient management and reduced quality of life. A recent study has shown that the
appearance of a fistula can be detected early by measuring cytokines (particularly IL10)
in postoperative drainage fluids. Resumption of feeding following this surgery varies
between postoperative day 5 and postoperative day 15, depending on the team's habits.
Early refeeding reduces the length of hospital stay and improves patients' quality of
life. The decision to refeed is currently made without any clinical or biological marker
of the quality of pharyngeal suture healing. The idea of this study is that good initial
healing (evidenced by low levels of inflammatory cytokine in drainage fluids) allows
early refeeding without putting the patient at additional risk.
Main hypothesis and research objectives Main hypothesis: the determination of cytokines
in postoperative drainage fluids (FODP) could be a tool for screening patients at no risk
of developing a fistula, and for whom early refeeding (as early as postoperative day 3)
could be proposed without exposing the patient to an additional risk of developing a
FODP.
Study objectives Primary objective: to compare the rate of post-(pharyngo)-total
laryngectomy fistula between an early refeeding strategy (3rd or 4th postoperative day)
and a late refeeding strategy (current standard of care: 7th postoperative day) in a
low-risk fistula group defined according to the level of inflammatory cytokines in
drainage fluids on the second postoperative day.
Secondary objectives
To compare an early versus a late refeeding strategy for patients at low risk of fistula
defined according to the level of inflammatory cytokines in drainage fluids on the second
postoperative day for:
- length of hospital stay,
- evolution of nutritional status,
- time to postoperative radio-chemotherapy, if indicated postoperatively,
- improvement in quality of life,
- post-operative complications other than pharyngeal fistula. Evaluation of different
strategies left to the investigator's choice (continuation of antibiotic
therapy, increased delay before resumption of feeding, early resumption of surgery)
in the group of patients at high risk of fistula, based on the determination of
postoperative cytokines in drainage fluids.
Primary endpoint: Pharyngo-cutaneous fistula occurring within 30 days post-operatively
(yes/no).
Number of subjects: 250 Inclusion criteria Major cancer patient justifying scheduled
total laryngectomy or pharyngo-laryngectomy after multidisciplinary consultation.
Holder of a social security plan. Non-inclusion criteria Pregnant and breast-feeding
women Persons under curatorship, guardianship, safeguard of justice or deprived of
liberty.
Any medical condition deemed incompatible with the study by the investigator. Refusal to
participate. Body mass index less than 18.5 kg/m2
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Ingrid BREUSKIN | 09/06/2026 18:35:05 | Contacter | ||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CH de Valence - Valence 2971053 - France | Lise Laclautre | Contact (sur clinicalTrials) | |||
| CHU de Clermont-Ferrand - Clermont-Ferrand 3024635 - France | Lise Laclautre | Contact (sur clinicalTrials) | |||
| CHU de Grenoble - Grenoble 3014728 - France | Lise Laclautre | Contact (sur clinicalTrials) | |||
| CHU de Saint-Etienne - Saint-Etienne 2980291 - France | Lise Laclautre | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CH Emile Roux - Le Puy-en-Velay 3002465 - France | Lise Laclautre | Contact (sur clinicalTrials) | |||
| HCL Hôpital Croix Rousse - Lyon 2996944 - France | Lise Laclautre | Contact (sur clinicalTrials) | |||
Critères
Tous
- Adult patient with cancer requiring a total laryngectomy or pharyngolaryngectomy
scheduled after multidisciplinary consultation.
- Holder of a social security scheme
Exclusion Criteria:
Pregnant and breastfeeding women Persons under curatorship, guardianship, legal
protection or deprived of liberty Any medical condition deemed by the investigator to be
incompatible with the study. Refusal to participate. Body mass index less than 18.5 kg/
m2
-